超24小时大血管闭塞卒中:血管内取栓与最佳药物治疗的系统综述与Meta分析
该系统综述与Meta分析纳入10项观察性研究共1871例患者,比较末次正常时间>24小时的大血管闭塞急性缺血性卒中患者接受血管内取栓(EVT)与最佳药物治疗的效果。EVT与更高的功能独立(调整OR 4.62,95%CI 3.30-6.47)和优良临床结局(调整OR 5.68,95%CI 2.49-12.97)相关,但症状性颅内出血风险增加(调整OR 9.54,95%CI 3.78-21.07),90天死亡率无显著差异(调整OR 0.63,95%CI 0.30-1.31)。证据确定性有限,需随机试验确认。
要点
- 超24小时窗EVT与功能独立改善相关(调整OR 4.62,95%CI 3.30-6.47,低证据确定性)。
- EVT增加症状性颅内出血风险(调整OR 9.54,95%CI 3.78-21.07),但90天死亡率无显著差异。
- 证据来自观察性研究且确定性有限,患者选择需谨慎并等待随机试验结果。
核心结论
- 超24小时窗EVT与改善功能结局相关且不增加90天死亡率,但症状性颅内出血风险更高。
- 因证据确定性有限,需正在进行的随机试验确认并指导超晚时间窗的患者选择。
研究设计与样本
- 系统检索PubMed、Embase、Scopus、Web of Science和Cochrane Central至2025年2月,纳入比较EVT与最佳药物治疗且末次正常时间>24小时的急性缺血性卒中研究。
- 共纳入10项观察性研究(3项前瞻性、7项回顾性),1871例患者(EVT 866例,最佳药物治疗1009例)。
- 采用随机效应Meta分析计算未调整和调整OR及95%CI,并按研究设计、卒中严重程度、影像 modality和闭塞区域进行亚组分析。
- 使用I²统计量和Cochran Q检验评估异质性,采用GRADE方法评估证据确定性。
主要发现
- EVT与更高的功能独立几率相关(8项研究;调整OR 4.62,95%CI 3.30-6.47;I²=0%;低证据确定性)。
- EVT与更高的优良临床结局几率相关(2项研究;调整OR 5.68,95%CI 2.49-12.97;I²=0%;极低证据确定性)。
- EVT增加症状性颅内出血风险(4项研究;调整OR 9.54,95%CI 3.78-21.07;I²=0%;低证据确定性)。
- 90天死亡率两组无显著差异(4项研究;调整OR 0.63,95%CI 0.30-1.31;I²=41.2%;极低证据确定性)。
- 所有亚组分析结果与主要发现一致。
关键数值与推荐
- 功能独立定义为90天改良Rankin量表评分0-2分。
- 优良临床结局定义为90天改良Rankin量表评分0-1分。
临床怎么用
- 对超24小时窗的大血管闭塞卒中患者,EVT可能改善功能结局但需权衡症状性颅内出血风险。
- 当前证据确定性有限,临床决策应个体化并考虑参与正在进行的随机试验。
局限性
- 纳入研究均为观察性研究(3项前瞻性、7项回顾性),整体研究质量有限。
- 证据确定性低至极低,主要结局的合并分析基于少量研究。
- 需随机试验确认超晚时间窗EVT的获益与风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The benefit of endovascular thrombectomy (EVT) beyond 24 hours from last known well in acute ischemic stroke remains uncertain. Although some slow progressors may retain salvageable tissue, supporting evidence in this ultra-late window comes mainly from small observational studies. METHODS: We systematically searched PubMed, Embase, Scopus, Web of Science, and Cochrane Central up to February 2025 for studies comparing EVT and best medical therapy in patients with acute ischemic stroke treated >24 hours from last known well. Eligible studies reported functional independence (90-day 0-2 modified Rankin Scale score), excellent clinical outcome (90-day 0-1 modified Rankin Scale score), symptomatic intracranial hemorrhage, or 90-day mortality. Pooled unadjusted and adjusted odds ratios (ORs) with 95% CIs were calculated using random-effects meta-analyses. Subgroup analyses were performed by study design, stroke severity, imaging modality, and occlusion territory. Statistical heterogeneity was assessed using the I² statistic and the Cochran Q test, and the certainty of evidence (CoE) was assessed using the Grading of Recommendation, Assessment, Development, and Evaluation approach. RESULTS: Ten observational studies (3 prospective and 7 retrospective) comprising 1871 patients (EVT: 866; best medical therapy: 1009) were included. EVT was associated with significantly higher odds of functional independence (8 studies; adjusted OR, 4.62 [95% CI, 3.30-6.47]; I²=0%; low CoE) and excellent clinical outcome (2 studies; adjusted OR, 5.68 [95% CI, 2.49-12.97]; I²=0%; very-low CoE). EVT increased the risk of symptomatic intracranial hemorrhage (4 studies; adjusted OR, 9.54 [95% CI, 3.78-21.07]; I²=0%; low CoE), but 90-day mortality did not differ significantly between groups (4 studies; adjusted OR, 0.63 [95% CI, 0.30-1.31]; I²=41.2%; very-low CoE). All subgroup analyses aligned with the main findings. CONCLUSIONS: Our results revealed that EVT was associated with improved functional outcomes without an increase in 90-day mortality, despite a higher symptomatic intracranial hemorrhage risk. Given the limited CoE and overall study quality, ongoing randomized trials are essential to confirm these findings and guide patient selection in the ultra-late time window.
引用
- Rodriguez-Calienes A, Borjas N, Sanikommu S, et al. Endovascular Thrombectomy Versus Best Medical Therapy for Large Vessel Occlusion Stroke Beyond 24 Hours: A Systematic Review and Meta-Analysis. Stroke. 2025. PMID: 40970285. doi:10.1161/STROKEAHA.125.052121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。